Abstract:
A composition is provided which contains a fluorinated alcohol represented by formula (1) and a charge transporting compound: CnFH2nF+1−mFFmFOH (1) nF and mF are each independently an integer of 1 or more and satisfy 2nF+1≥mF. An amount of hydrogen fluoride generated from the fluorinated alcohol under atmospheric pressure at 25° C. is 5.0 ppm by volume or less.
Abstract:
Lanthanide fluorinated alkoxide derivatives can be synthesized from the alcoholysis reaction of the lanthanide bis-trimethylsilyl amide and an excess amount of hexafluoro iso-propanol. Nanoparticles can be formed from the lanthanide fluorinated alkoxide derivatives by a solvothermal or solution precipitation process.
Abstract:
A polar compound has a high chemical stability, high ability to align liquid crystal molecules and high solubility in a liquid crystal composition, and causes no decrease of liquid crystallinity of the liquid crystal composition, a liquid crystal composition contains the compound, and a liquid crystal display device includes the composition.The compound is represented by formula (1), the composition contains the compound, and the liquid crystal display device uses the composition. In formula (1), R1 is alkyl having 3 to 15 carbons, alkenyl having 4 to 15 carbons or the like; a is an integer from 2 to 12; and R2 is a group represented by formula (1a), formula (1b) or formula (1c). In the formulas, S1 and S2 are independently a single bond, alkylene having 1 to 10 carbons; S3 is >CH— or >N—; S4 is >C Si
Abstract:
The present invention relates to novel Ruthenium complexes of formulae A1-A4 and their use, inter alia, for (1) dehydrogenative coupling of alcohols to esters; (2) hydrogenation of esters to alcohols (including hydrogenation of cyclic esters (lactones) or cyclic di-esters (di-lactones), or polyesters); (3) preparing amides from alcohols and amines—(including the preparation of polyamides (e.g., polypeptides) by reacting dialcohols and diamines and/or polymerization of amino alcohols and/or forming cyclic dipeptides from p-aminoalcohols; (4) hydrogenation of amides (including cyclic dipeptides, polypeptides and polyamides) to alcohols and amines; (5) hydrogenation of organic carbonates (including polycarbonates) to alcohols or hydrogenation of carbamates (including polycarbamates) or urea derivatives to alcohols and amines; (6) dehydrogenation of secondary alcohols to ketones; (7) amidation of esters (i.e., synthesis of amides from esters and amines); (8) acylation of alcohols using esters; (9) coupling of alcohols with water and a base to form carboxylic acids; and (10) preparation of amino acids or their salts by coupling of amino alcohols with water and a base. The present, invention further relates to the use of certain known Ruthenium complexes for the preparation of amino acids or their salts from amino alcohols.
Abstract:
The present invention is directed to a process for preparation of fluorinated alcohols of Formula (I) RfCH2CH2OH (I) by contacting a fluorinated iodide with an alkyl vinyl ether in the presence of an initiator and a base to generate an intermediate hemi-acetal or aldehyde or a mixture thereof, followed by hydrogenation of the hemi-acetal of Formula (II) RfCH2CH(OCxH2x+1)m(OH)p (II) or aldehyde of Formula (III) RfCH2CHO (III) or a mixture thereof, to yield a compound of Formula (I).
Abstract translation:本发明涉及通过在引发剂和碱的存在下使氟化碘与烷基乙烯基醚接触以制备中间体半缩醛或醛的式(I)RfCH 2 CH 2 OH(I)的氟化醇的方法 或其混合物,然后氢化式(II)的RfRCH 2 CH(OC x H 2 x + 1)m(OH)p(II)或式(III)的醛R fCH 2 CHO(III)的半缩醛或其混合物,得到 式(I)的化合物。
Abstract:
The problem to be resolved by the present invention is to provide a method for efficiently synthesizing optically active lower aliphatic alcohols that have difficulty in separation from organic solvents, without using a special reactor.The present invention relates to a method for producing an optically active aliphatic alcohol having a fluorine atom at α position, wherein an optically active alcohol is produced by reacting an aliphatic ketone having a fluorine atom at α position in water using a formate, under the presence of an asymmetric catalyst represented by general formula (1) and an acid.
Abstract:
1,1,1,3,3,3-Hexafluoroisopropanol (HFIP) substantially free of 1,1,1-trifluoroacetone (TFA) can be separated from a mixture containing both compounds by A) catalytic reduction with hydrogen followed by fractional distillation; B) cooling to a temperature at which HFIP freezes and TFA remains liquid; C) forming a high boiling complex comprising HF and TFA followed by fractional distillation; or D) producing HF-free conditions to yield a HFIP/TFA azeotrope followed by fractional distillation. It is emphasized that this abstract is provided to comply with the rules requiring an abstract, which will allow a searcher or other reader to quickly ascertain the subject matter of the technical disclosure. It is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims. 37 CFR § 1.72(b).
Abstract:
The invention relates to the preparation of enantiomerically pure (S)-1,1,1-trifluoro-2-propanol by asymmetric hydrogenation of 1,1,1-trifluoroacetone which process comprises hydrogenating 1,1,1-trifluoroacetone in the presence of a ruthenium phosphine complex catalyst represented by formula Ru(E)(E′)(L)(A) wherein E, E′ are both chloro or E is hydrogen and E′ is BH4; L is a chiral diphosphine ligand; and A is an optionally chiral diamine wherein hydrogenation occurs in the presence of a weak base, with or without an additive, when E and E′ are both chloro or b) in the absence of a base and an additive when E and E′ are hydrogen and BH4.
Abstract:
Provided is a process of obtaining 1,1,1,3,3,3-hexafluoro-2-propanol (“HFIP”) from a composition comprising an HFIP hydrolyzable precursor. The HFIP hydrolyzable precursor is a compound, other than sevoflurane itself, that has an intact 1,1,1,3,3,3-hexafluoroisopropoxy moiety[(CF3)2CHO—], and contains one or more moieties susceptible to acidic hydrolysis, such that HFIP is released upon such treatment. The process is useful, among other things, for recovering HFIP from waste streams associated with the synthesis of the inhalation anesthetic, fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether (“sevoflurane”). The process includes heating the composition with a strong protic acid to a temperature effective to hydrolyze at least some of the HFIP hydrolyzable precursor to HFIP, and then isolating the HFIP from the heated composition.
Abstract:
A ruthenium complex RuCl[(S,S)-Tsdpen](p-cymene) represented by a formula below and a ketone compound are placed in a polar solvent, and the resulting mixture is mixed under pressurized hydrogen to hydrogenate the ketone compound and to thereby produce an optically active alcohol: